ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: physical function

A Community Connection

Catherine Kolonko  |  November 19, 2025

Dr. Heidi Prather detailed how social prescription may aid patients with chronic diseases and the research supporting this approach to care in her keynote speech during ACR Convergence 2025.

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2025patient carePractice Managementsocial perscription

Peripheral Neuropathy Common Among Patients with Sjögren’s Disease

Vanessa Caceres  |  November 18, 2025

At this ACR Convergence session, experts discussed the peripheral nervous system involvement with Sjögren’s disease that can have several manifestations.

Filed under:ACR ConvergenceMeeting ReportsSjögren’s Disease Tagged with:ACR Convergence 2025imagingPeripheral NeuropathySjögren's Disease

Complicated Cases Discussed in Pediatric Thieves Market

Thomas R. Collins  |  November 14, 2025

At this ACR Convergence 2025 session, clinicians discussed complex and difficult-to-diagnose pediatric cases.

Filed under:ACR ConvergenceMeeting ReportsPediatric Conditions Tagged with:ACR Convergence 2025case reportpatient carepediatric conditions

3 AC&R Study Summaries: RA & Frailty, Hydroxychloroquine Can Protect Kidneys in Lupus Nephritis, & PT for Knee OA

Arthritis Care & Research  |  November 11, 2025

Research on PT for knee OA, HCQ’s protective role in lupus nephritis & the link between RA disease activity & frailty.

Filed under:ConditionsGuidanceOsteoarthritis and Bone DisordersResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RArthritis Care & ResearchfrailtyHydroxychloroquine (HCQ)kidney diseaseknee osteoarthritisLupus nephritisPhysical TherapyReferral

As Understanding of Long COVID Deepens, the Search for Therapies Continues

Thomas R. Collins  |  November 7, 2025

Experts discussed causes of long COVID & potential therapies at this ACR Convergence 2025 session.

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2025COVID-19long COVID

Differentiating POTS from Other Conditions

Mary Beth Nierengarten  |  November 6, 2025

At a ACR Convergence 2025 session, two experts discussed POTS, the importance of considering dysautonomia when making a differential diagnosis & an interdisciplinary approach to treatment.

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2025DysautonomiaPOTS

JIA: The Transition to Adult Care

Ruth Jessen Hickman, MD  |  November 5, 2025

Experts addressed considerations for how to aid patients with juvenile idiopathic arthritis (JIA) in their transition to adult care, specifically highlighting clinical pearls for those with pediatric uveitis and TMJ arthritis.

Filed under:ACR ConvergenceConditionsMeeting ReportsPediatric Conditions Tagged with:ACR Convergence 2025JIAJIA-associated uveitisjuvenile idiopathic arthritis (JIA)pediatric arthritistemporomandibular joint (TMJ)

Does High-Intensity Interval Training Lower Inflammatory Disease Activity?

Kurt Ullman  |  November 4, 2025

Experts discuss high-intensity interval training as an underused “disease-modifying drug” for inflammatory diseases. Learn how to safely integrate it into patient treatment plans.

Filed under:ACR ConvergenceConditionsPsoriatic ArthritisRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - PsAACR Convergence 2025 - RADisease Activity Score (DAS)ExercisefatigueFlaresHIITInflammatory Diseasephysical activity

Meet Incoming ARP President Rebecca Cleveland

Leslie Mertz, PhD  |  October 29, 2025

Incoming ARP President Dr. Rebecca Cleveland discusses her plans for advocacy, ACR/ARP collaboration, & tackling workforce shortages in rheumatology.

Filed under:ACR ConvergenceInterprofessional PerspectivePractice SupportProfilesWorkforce Tagged with:ACR Convergence 2025advanced practice provider (APP)ARP presidentAssociation of Rheumatology Professionals (ARP)Dr. Rebecca ClevelandepidemiologyOsteoarthritisVolunteerismWorkforce

Let’s Discuss Part 2: More Insights from the ACR Convergence 2025 Review Course

Jason Liebowitz, MD, FACR  |  October 28, 2025

The Review Course at ACR Convergence 2025 provided a comprehensive update for practitioners. Highlights from the sections on cutaneous manifestations of rheumatic diseases, gout, macrophage activation syndrome and vasculitis.

Filed under:ACR ConvergenceAmerican College of RheumatologyGout and Crystalline ArthritisMeeting ReportsOther Rheumatic ConditionsSystemic Lupus ErythematosusVasculitis Tagged with:ACR Convergence 2025GoutLupusmacrophage activation syndromeMethotrexatesystemic lupus erythematosus (SLE)Vasculitis

  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 83
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences